Stocks News

LAST PRICE
826.8800
TODAY'S CHANGE (%)
Trending Down-5.5600 (-0.6679%)

Bid / Lots
826.6700/ 8
Ask / Lots
827.4100/ 8
Open / Previous Close
830.2000 / 832.4400
Day Range
Low 810.7201
High 833.9900
52 Week Range
Low 561.6500
High 972.5300
Volume
2,336,852
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- Daiwa Adjusts Price Target on Eli Lilly & Co. to $900 From $940, Maintains Outperform Rating, from 9 hours ago by MT Newswires
  9 hours ago by MT Newswires
  Companies Mentioned: LLY
  05:18 AM EST, 11/12/2024 (MT Newswires) -- Eli Lilly & Co. (LLY) has an average outperform rating and a price target range of $580 to $1,250, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research fr...
Yesterday
- DJ Novo Stock Has Been Slammed. How a New Weight-Loss Drug Could Boost Shares by 10%. -- Barrons.com, from 12:20PM ET on Monday Nov 11, 2024 by Dow Jones
  12:20PM ET on Monday Nov 11, 2024 by Dow Jones
  Companies Mentioned: LLY, NVO
  
  By Elsa Ohlen
  
  Novo Nordisk is working on a new obesity drug that could help patients shed more than any other weight-loss drug on the market. Results from a late-stage clinical trial are expected in December of this year and, if positive, could reignite Novo shares.
- CICC Adjusts Price Target on Eli Lilly & Co. to $832 From $920.20, Maintains Neutral Rating, from 5:36AM ET on Monday Nov 11, 2024 by MT Newswires
  5:36AM ET on Monday Nov 11, 2024 by MT Newswires
  Companies Mentioned: LLY
  05:36 AM EST, 11/11/2024 (MT Newswires) -- Eli Lilly & Co. (LLY) has an average outperform rating and a price target range of $580 to $1,250, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research fr...
Nov 8, 2024
- Novo Nordisk Earnings Ease Investor Concerns, Put Focus on New Obesity Drug Trial, from 10:45AM ET on Friday Nov 08, 2024 by MT Newswires
  10:45AM ET on Friday Nov 08, 2024 by MT Newswires
  Companies Mentioned: LLY, NVO, CTLT
  10:45 AM EST, 11/08/2024 (MT Newswires) -- Novo Nordisk's (NVO) third-quarter earnings were solid enough to soothe investor jitters and turn the market's attention toward upcoming trial results for a potentially game-changing new weight-loss drug, a...
Nov 6, 2024
- DJ Eli Lilly Currently Down Six Consecutive Days, on Pace for Longest Losing Streak Since August 2022 -- Data Talk, from 12:18PM ET on Wednesday Nov 06, 2024 by Dow Jones
  12:18PM ET on Wednesday Nov 06, 2024 by Dow Jones
  Companies Mentioned: LLY
  
  Eli Lilly and Company ( LLY ) is currently at $774.76, down $31.30 or 3.88%
  
  --Would be lowest close since Aug. 7, 2024, when it closed at $772.14
  
  --Currently down six consecutive days; down 14.26% over this period

Today
- DJ AstraZeneca Expands U.S. Investment Plan -- 3rd Update, from 27 minutes ago by Dow Jones
  27 minutes ago by Dow Jones
  Companies Mentioned: AZN
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN, from 36 minutes ago by Dow Jones
  36 minutes ago by Dow Jones
  Companies Mentioned: AZN
- DJ Trending: AstraZeneca Expands Its Investment Plan in the U.S., from 45 minutes ago by Dow Jones
  45 minutes ago by Dow Jones
  Companies Mentioned: AZN
- DJ AbbVie Is Maintained at Buy by Citigroup, from 59 minutes ago by Dow Jones
  59 minutes ago by Dow Jones
  Companies Mentioned: ABBV
- DJ Novartis AG Falls Tuesday, Outperforms Market, from 2 hours ago by Dow Jones
  2 hours ago by Dow Jones
  Companies Mentioned: NVS
- DJ AstraZeneca PLC Stock Rises Tuesday, Outperforms Market, from 3 hours ago by Dow Jones
  3 hours ago by Dow Jones
  Companies Mentioned: AZN
- DJ AbbVie Is Maintained at Outperform by BMO Capital, from 3 hours ago by Dow Jones
  3 hours ago by Dow Jones
  Companies Mentioned: ABBV
- UBS Lowers Price Target on AbbVie to $181 From $200, Keeps Neutral Rating, from 4 hours ago by MT Newswires
  4 hours ago by MT Newswires
  Companies Mentioned: ABBV
- DJ AstraZeneca Expands U.S. Investment Plan -- 2nd Update, from 4 hours ago by Dow Jones
  4 hours ago by Dow Jones
  Companies Mentioned: AZN
- *DJ AstraZeneca's Plans to Invest in U.S. Made in Reaction to U.S. Election, Source Says, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: AZN

Eli Lilly and Co
NYSE:LLYUnited States

Search Criteria

Today

Daiwa Adjusts Price Target on Eli Lilly & Co. to $900 From $940, Maintains Outperform Rating, from 9 hours ago by MT Newswires

Yesterday

DJ Novo Stock Has Been Slammed. How a New Weight-Loss Drug Could Boost Shares by 10%. -- Barrons.com, from 12:20PM ET on Monday Nov 11, 2024 by Dow Jones

CICC Adjusts Price Target on Eli Lilly & Co. to $832 From $920.20, Maintains Neutral Rating, from 5:36AM ET on Monday Nov 11, 2024 by MT Newswires

Nov 8, 2024

Novo Nordisk Earnings Ease Investor Concerns, Put Focus on New Obesity Drug Trial, from 10:45AM ET on Friday Nov 08, 2024 by MT Newswires

Nov 6, 2024

DJ Eli Lilly Currently Down Six Consecutive Days, on Pace for Longest Losing Streak Since August 2022 -- Data Talk, from 12:18PM ET on Wednesday Nov 06, 2024 by Dow Jones

Peers Headlines

Today

DJ AstraZeneca Expands U.S. Investment Plan -- 3rd Update, from 27 minutes ago by Dow Jones

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN, from 36 minutes ago by Dow Jones

DJ Trending: AstraZeneca Expands Its Investment Plan in the U.S., from 45 minutes ago by Dow Jones

DJ AbbVie Is Maintained at Buy by Citigroup, from 59 minutes ago by Dow Jones

DJ Novartis AG Falls Tuesday, Outperforms Market, from 2 hours ago by Dow Jones

DJ AstraZeneca PLC Stock Rises Tuesday, Outperforms Market, from 3 hours ago by Dow Jones

DJ AbbVie Is Maintained at Outperform by BMO Capital, from 3 hours ago by Dow Jones

UBS Lowers Price Target on AbbVie to $181 From $200, Keeps Neutral Rating, from 4 hours ago by MT Newswires

DJ AstraZeneca Expands U.S. Investment Plan -- 2nd Update, from 4 hours ago by Dow Jones

*DJ AstraZeneca's Plans to Invest in U.S. Made in Reaction to U.S. Election, Source Says, from 5 hours ago by Dow Jones